Clinical

Dataset Information

0

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

ABSTRACT: RATIONALE: Vaccines may make the body build an immune response that will kill cancer cells. Combining vaccine therapy with interleukin-2 may kill more cancer cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy with or without interleukin-2 in treating patients who have locally advanced or metastatic colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2006405 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
| 2006387 | ecrin-mdr-crc
Clinical Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer
| 2006375 | ecrin-mdr-crc
Clinical Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
| 2005639 | ecrin-mdr-crc
Clinical Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer
| 2005419 | ecrin-mdr-crc
Clinical Vaccine Therapy in Treating Patients With Metastatic Cancer
| 2006441 | ecrin-mdr-crc
Clinical Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
| 2007006 | ecrin-mdr-crc
Clinical Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
| 2007376 | ecrin-mdr-crc
Clinical Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
| 2006942 | ecrin-mdr-crc
Clinical Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer
| 2011380 | ecrin-mdr-crc
Clinical Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
| 2002163 | ecrin-mdr-crc